NCT00535509已完成不适用

Phase II Trial of Neoadjuvant[FEC100]/Cisplatin-Docetaxel ± Trastuzumab in Women With Over Expressed or Amplified Her2/Neu With Locally Advanced Breast Cancer

King Faisal Specialist Hospital & Research Center0 个研究点目标入组 285 人开始时间: 2007年6月最近更新: 2015年12月17日

研究概览

简要总结

Phase II trial of Neoadjuvant [FEC100]/Cisplatin-Docetaxel ± Trastuzumab in women with over expressed or amplified Her2/Neu with Locally advanced Breast Cancer

研究设计

研究类型: Interventional
分配方式: Na
干预模型: Single Group
主要目的: Treatment
盲法: None

入排标准

性别: Female
接受健康志愿者: 否

入选标准

•Patients with locally advanced breast cancer

排除标准

未提供

结局指标

主要结局

Efficacy

时间窗: overall

次要结局

未报告次要终点

研究者

发起方

King Faisal Specialist Hospital & Research Center

申办方类型

Other

责任方

Principal Investigator

主要研究者

Dr. Naeem A. Chaudhri

Principal Investigator

King Faisal Specialist Hospital & Research Center

相似试验

已完成

2 期

Phase II trial of neoadjuvant docetaxel + cisplatin + fluorouracil (DCF) therapy for esophageal cancerEsophageal cancer

JPRN-UMIN000028252agoya University28

已完成

2 期

Neoadjuvant Therapy in Clinical Stage I-III HER2-positive Breast Cancer.Breast Cancer

NCT02789657Brown University32

已完成

1 期

Docetaxel, Cisplatin, and Erlotinib Hydrochloride in Treating Patients With Stage I-III Non-small Cell Lung Cancer Following SurgeryRecurrent Lung Non-Small Cell CarcinomaStage IA Lung Non-Small Cell Carcinoma AJCC v7Stage IB Lung Non-Small Cell Carcinoma AJCC v7Stage IIA Lung Non-Small Cell Carcinoma AJCC v7Stage IIB Lung Non-Small Cell Carcinoma AJCC v7Stage IIIA Lung Non-Small Cell Cancer AJCC v7Stage IIIB Lung Non-Small Cell Cancer AJCC v7

NCT00254384M.D. Anderson Cancer Center50

尚未招募

2 期

Phase II Study of the Use of Neoadjuvant Cabazitaxel With Hormonal Treatment in Patients Operable Prostate Cancer, Assess the Efficacy and Toxicity of Cabazitaxel, and Explore Potential Predictive and Prognostic Markers of Clinical OutcomeProstate Cancer

NCT04622761The Clatterbridge Cancer Centre NHS Foundation Trust120

Unknown

2 期

Induction Chemotherapy Followed by Concurrent Radiation With Cetuximab or Cisplatin in Locally Advanced Nasopharyngeal CancerNasopharyngeal Carcinoma

NCT01614938Fudan University46